Clinical and microbial efficacy of antimicrobial treatments of experimental avian colibacillosis

Veterinary Microbiology

Volumn 149, Issue 3-4, 2011, Pages 422-429

  Dheilly, Alexandra ^a   Bouder, Axelle ^a   Le Devendec, Laëtitia ^a   Hellard, Gwenaëlle ^a   Kempf, Isabelle ^a  

^a FRENCH AGENCY FOR FOOD   (France)

Author keywords

Antimicrobial treatment; Avian colibacillosis; Resistance gene transfer

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFOXITIN; CEFTIOFUR; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; KANAMYCIN; NALIDIXIC ACID; RIFAMPICIN; STREPTOMYCIN; TETRACYCLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; CHICKEN; CONTROLLED STUDY; DRUG EFFICACY; ESCHERICHIA COLI INFECTION; EXPERIMENTAL INFECTION; FEMALE; MALE; MULTIDRUG RESISTANCE; NONHUMAN; SEPTIC SHOCK;

AMOXICILLIN; ANIMALS; ANTI-BACTERIAL AGENTS; CHICKENS; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; FLUOROQUINOLONES; MALE; OXYTETRACYCLINE; PLASMIDS; POULTRY DISEASES; SULFADIMETHOXINE; TRIMETHOPRIM;

AVES; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; GALLUS GALLUS;

EID: 79953058240     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetmic.2010.11.033     Document Type: Article

References (26)

1. Barnes H.J., Vaillancourt J.P., Gross W.B. Colibacillosis. Diseases of Poultry 2003, 631-656. Iowa Stat Press, Ames, IA, USA. Y.M. Saif (Ed.).
2. Bouder A., Hellard G., Kempf I. Experimental infection of SPF chickens with qnr, ESBL or plasmidic AmpC genes bearing E. coli strains. Antimicrobial Resistance in Animals and Environment 2009.
3. CA-SFM Recommandations 2008 du Comité de l'antibiogramme de la société française de microbiologie 2008.
4. Cattoir V., Poirel L., Rotimi V., Soussy C.J., Nordmann P. Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates. The Journal of Antimicrobial Chemotherapy 2007, 60:394-397.
5. Chauvin C., Clement C., Bruneau M., Pommeret D. Time-patterns of antibiotic exposure in poultry production-a Markov chains exploratory study of nature and consequences. Preventive Veterinary Medicine 2007, 80:230-240.
6. Chauvin C., Le Bouquin-Leneveu S., Hardy A., Haguet D., Orand J.P., Sanders P. An original system for the continuous monitoring of antimicrobial use in poultry production in France. Journal of Veterinary Pharmacology and Therapeutics 2005, 28:515-523.
7. Chazel, M., Jouy, E., Meunier, D., Haenni, M., Gay, E., Calavas, D., Madec, J.Y., 2009. Resapath, réseau d'épidémiosurveillance de l'antibiorésistance des bactéries pathogènes animales. Bilan 2008, http://www.afssa.fr/Documents/LABO-Ra-Resapath2008EN.pdf.
8. Chu G., Vollrath D., Davis R.W. Separation of large DNA molecules by contour-clamped homogeneous electric fields. Science 1986, 234:1582-1585.
9. CLSI M31-A3, Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals; Approved Standard 2008, third edition.
10. Dheilly A., Le Devendec L., Bouder A., Hellard G., Balan O., Amelot M., Kempf I. Sélection et transferts de gènes de résistance dans la flore digestive de poulets traités par différents antibiotiques. 8ème congrès national de la société française de microbiologie 2010, 207.
11. Garmyn A., Martel A., Froyman R., Nauwynck H., Duchateau L., Haesebrouck F., Pasmans F. Effect of multiple- and single-day enrofloxacin medications against dual experimental infection with avian pneumovirus and Escherichia coli in turkeys. Poultry Science 2009, 88:2093-2100.
12. Gay K., Robicsek A., Strahilevitz J., Park C.H., Jacoby G., Barrett T.J., Medalla F., Chiller T.M., Hooper D.C. Plasmid-mediated quinolone resistance in non-Typhi serotypes of Salmonella enterica. Clinical Infectious Diseases 2006, 43:297-304.
13. Holzheimer R.G. Antibiotic induced endotoxin release and clinical sepsis: a review. Journal of Chemotherapy 2001, 13:159-172.
14. Huang S.Y., Dai L., Xia L.N., Du X.D., Qi Y.H., Liu H.B., Wu C.M., Shen J.Z. Increased prevalence of plasmid-mediated quinolone resistance determinants in chicken Escherichia coli isolates from 2001 to 2007. Foodborne Pathogens and Disease 2009, 6:1203-1209.
15. Jacoby G.A., Chow N., Waites K.B. Prevalence of plasmid-mediated quinolone resistance. Antimicrobial Agents and Chemotherapy 2003, 47:559-562.
16. Jacoby G.A., Walsh K.E., Mills D.M., Walker V.J., Oh H., Robicsek A., Hooper D.C. qnrB, another plasmid-mediated gene for quinolone resistance. Antimicrobial Agents and Chemotherapy 2006, 50:1178-1182.
17. Kempf I., Gesbert F., Guittet M., Froyman R., Delaporte J., Bennejean G. Dose titration study of enrofloxacin (Baytril) against respiratory colibacillosis in Muscovy ducks. Avian Diseases 1995, 39:480-488.
18. Kesteman A.S., Ferran A.A., Perrin-Guyomard A., Laurentie M., Sanders P., Toutain P.L., Bousquet-Mélou A. Influence of inoculum size and marbofloxacin plasma exposure on the amplification of resistant subpopulations of Klebsiella pneumoniae in a rat lung infection model. Antimicrobial Agents and Chemotherapy 2009, 53:4740-4748.
19. Le Devendec, L., Bouder, A., Dheilly, A., Hellard, G., Kempf, I. Persistence and spread of qnr, ESBL and ampC resistance genes in the digestive tract of chickens. Microbial Drug Resistance, in press.
20. Lepper P., Held T., Schneider E., Bollke E., Gerlach H., Trautmann M. Clinical implications of antibiotic-induced endotoxin release in septic shock. Intensive Care Medicine 2002, 28:824-833.
21. Melhus A. Effects of amoxicillin on the expression of cytokines during experimental acute otitis media caused by non-typeable Haemophilus influenzae. Journal of Antimicrobial Chemotherapy 2001, 48:397-402.
22. Peighambari S.M., Julian R.J., Gyles C.L. Experimental Escherichia coli respiratory infection in broilers. Avian Diseases 2000, 44:759-769.
23. Perez-Perez F.J., Hanson N.D. Detection of plasmid-mediated AmpC I2-lactamase genes in clinical isolates by using multiplex PCR. Journal of Clinical Microbiology 2002, 40:2153-2162.
24. Robicsek A., Jacoby G.A., Hooper D.C. The worldwide emergence of plasmid-mediated quinolone resistance. The Lancet Infectious Diseases 2006, 6:629-640.
25. Shenep J.L., Barton R.P., Mogan K.A. Role of antibiotic class in the rate of liberation of endotoxin during therapy for experimental Gram-negative bacterial sepsis. Journal of Infectious Diseases 1985, 151:1012-1018.
26. Strahilevitz J., Jacoby G.A., Hooper D.C., Robicsek A. Plasmid-mediated quinolone resistance: a multifaceted threat. Clinical Microbiology Reviews 2009, 22:664-689.